Case-control Study: Comparative Evaluation of Bio active Glass (Novabone Putty) and Demineralized Freeze-dried Bone Allograft in the Treatment of Mandibular Furcation Defects
Citation Information :
Sen A, Rajan P, Kumar V, Mukherjee A, Sahoo R, Kumar C. Case-control Study: Comparative Evaluation of Bio active Glass (Novabone Putty) and Demineralized Freeze-dried Bone Allograft in the Treatment of Mandibular Furcation Defects. J Contemp Dent Pract 2024; 25 (7):696-702.
Aim: The aim of this study was to compare a second-generation bioactive glass putty biomaterial (Novabone putty) against demineralized freeze-dried bone allograft (DFDBA) in mandibular grade II furcation defects.
Materials and methods: Fifteen systematically healthy individuals in the age range of 38–50 years were selected for this split-mouth study. Group I consisting of 15 sites, was treated with DFDBA and group II consisting of 15 sites was treated with Novabone putty (NB putty). The clinical parameters recorded at 0, 3 and 6 months included plaque index (PI), gingival index (GI), probing pocket depth (PPD), relative vertical attachment level (RVAL) and relative horizontal attachment level (RHAL). Standardized intraoral periapical radiographs were taken at all 30 sites pre-and 6 months post-operatively.
Results: Probing pocket depth reduced significantly (p = 0.001) when baseline values were compared to 3 and 6 months postoperatively. In group II mean RVAL changed from 6.56 ± 1.44 at baseline to 4.80 ± 1.14 at 3 months and 4.80 ± 1.33 at 6 months which was found to be highly significant (HS) (p = 0.001). The mean RHAL also showed a significant difference when baseline values were compared to 6 months post-operatively in both the groups. With respect to defect depth and bone density, no significant difference was found between the two groups.
Conclusion: Significant improvement of the clinical parameters were seen in both the groups. As both the groups showed increase in defect fill and bone density, it can be summarized that NB putty seems to have comparable regeneration property to that of DFDBA when used for mandibular grade II furcation defects.
Clinical significance: The ease of use and higher level of biological performance of second-generation bioactive glass putty make it an ideal graft material.
Bansal M, Singh TB. The efficacy of transgingival probing in class II buccal furcation defects treated by guided tissue regeneration. J Indian Soc Periodontol 2016;20(4):391–395. DOI: 10.4103/0972-124X.189222.
De Leonardis DD, Garg AK, Pedrazzoil V, et al. Clinical evaluation of the treatment of class II furcation involvements with bioabsorbable barriers alone or associated with demineralized freeze-dried bone allograft. J Periodontol 1999;70(1):8–12. DOI: 10.1902/jop.1999.70.1.8.
Horwitz J, Machtei EE, Reitmeir P, et al. Radiographic parameters as prognostic indicators for healing of class II furcation defects. J Clin Periodontol 2004;31(2):105–111. DOI: 10.1111/j.0303-6979.2004.00455.x.
Klingsberg J. Preserved sclera in periodontal surgery. J Periodontol 1972;43(10):634–639. DOI: 10.1902/jop.1972.43.10.634.
Sepe WW, Bowers GM, Lawrence JJ, et al. Clinical evaluation of freeze-dried bone allografts in periodontal osseous defects – part II. J Periodontol 1978;49(1):9–14. DOI: 10.1902/jop.1978.49.1.9.
Biswas S, Sambashivalah S, Kulal R, et al. Comparative evaluation of bioactive glass (putty) and platelet rich fibrin in treating furcation defects. J Oral Imp 2016;42(5):411–415. DOI: 10.1563/aaid-joi-D-16-00023.
Urist M. Bone formation by autoinduction. Science 1965;150(3698): 893–899. DOI: 10.1126/science.150.3698.893.
Reddi AH, Huggins C. Biochemical sequences in the transformation of normal fibroblasts in adolescent rats. Proc Nalt Acad Sci USA 1972;69(6):1601–1605. DOI: 10.1073/pnas.69.6.1601.
Reddi AH, Wientroub S, Muthukmuaran N. Biologic principles of bone induction. Orthop Clin North Am 1987;18(2):207–212. PMID: 3561974.
Reddi AH. Cell biology and biochemistry of endochondral bone development. Collagen Rel Res 1981;1(2):209–226. DOI: 10.1016/S0174-173X(81)80021-0.
Valimaki VV, Aro HT. Molecular basis for action of bioactive glasses as bone graft substitute. Scand Jour Surg 2006;95(2):95–102. DOI: 10.1177/145749690609500204.
Mengel R, Soffner M, Flores-de-Jacoby L. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: Results of a 12-month clinical and radiological study. J Periodontol 2003;74(6):899–908. DOI: 10.1902/jop.2003.74.6.899.
Wang Z, Lu B, Chen L, et al. Evaluation of an osteostimulative putty in the sheep spine. J Mat Sci Mat Metho 2011;22(1):185–191. DOI: 10.1007/s10856-010-4175-5.
Machtei EE, Schallhorn R. Successful regeneration of mandibular Class II furcation defects: An evidence-based treatment approach. Int J Periodontics Restorative Dent 1995;15(2):146–167. PMID: 8593980.
Yukna CN, Yukna RA. Multi-center evaluation of bioabsorbable collagen membrane for guided tissue regeneration in human class II furcations. J Periodontol 1996;67(7):650–657. DOI: 10.1902/jop.1996.67.7.650.
Pontoriero R, Lindhe J, Nyman S, et al. Guided tissue regeneration in degree II furcation – involved mandibular molars. A clinical study. J Clin Periodontol 1988;15(4):247–254. DOI: 10.1111/j.1600-051x.1988.tb01578.x.
Libin BM, Ward HL, Fishman L. Decalcified, lyophilized bone allograft for use in human periodontal defects. J Periodontol 1975;46(1):51–56. DOI: 10.1902/jop.1975.46.1.51.
Gonshor A, Saroff SA, Anderegg CR, et al. Histologic and clinical evaluation of bioactive calcium phosphosilicate bone graft material in post extraction alveolar sockets. Int J Oral Implants Clin Res 2011;2(2):79–84. DOI: 10.5005/jp-journals-10012-1040.
Shapoff CA, Bowers GM, Levy B, et al. The effect of particle size on the osteogenic activity of composite grafts of allogeneic freeze-dried bone and autogenous marrow. J Periodontol 1980;51(11):625–630. DOI: 10.1902/jop.1980.51.11.625.
Gross U, Schmitz HJ, Strunz V. Surface activities of bioactive glass, aluminium oxide, and titanium in a living environment. Ann. N.Y. Acad Sci 1988;523(1):211–226. DOI: 10.1111/j.1749-6632.1988.tb38514.x.
Ducheyne P, Brown S, Blumenthal N, et al. Bioactive glasses, aluminum oxide and titanium. Ion transport phenomenon and surface analysis. Ann. N.Y. Acad Sci 1988;523:257–261. DOI: 10.1111/j.1749-6632.1988.tb38517.x.
Asmita, Gupta V, Bains VK, et al. Clinical and cone beam computed tomography comparison of NovaBone dental putty and PerioGlas in the treatment of mandibular class II furcations. Int J Dent Res 2014;25(2):166–173. DOI: 10.4103/0970-9290.135912.
Grover V, Kapoor A, Malhotra R, et al. Bonegraft: A review of safety and efficacy. Indian J Dent Res 2011;22(3):532–537. DOI: 10.4103/0970-9290.87084.
Cortellini P, Bowers GM. Periodontal regeneration of intrabony defects: An evidence- based treatment approach. Int J Periodontics Restorative Dent 1995;15(2):128–145. PMID: 8593979.
Wallace SC, Gellin RG, Miller MC, et al. Guided tissue regeneration with and without decalcified freeze dried bone in mandibular class II furcation invasions. J Periodontol 1994;65(3):244–254. DOI: 10.1902/jop.1994.65.3.244.
Anderegg CR, Alexander DC, Friedman M. A bioactive glass particulate in the treatment of molar furcation invasions. J Periodontol 1999;70(4):384–387. DOI: 10.1902/jop.1999.70.4.384.
Guillemin MR, Mellonig JT, Brunsvold MA. Healing in periodontal defects treated by decalcified freeze-dried bone allografts in combination with eFTFE membranes (I). Clinical and scanning electron microscope analysis. J Clin Periodontol 1993;20(7):528–536. DOI: 10.1111/j.1600-051x.1993.tb00402.x.
Tonetti MS, Pini Prato G, Cortellini P. Periodontal regeneration of human intrabony defects. IV. Determinants of healing response. J Periodontol 1993;64(10):934–940. DOI: 10.1902/jop.1993.64.10.934.
Eickholz P, Pretzl B, Holle R, et al. Long term results of guided tissue regeneration therapy with non-resorbable and bioabsorbable barriers (III). Class II furcations after 10 years. J Periodontol 2006;77(1):88–94. DOI: 10.1902/jop.2006.77.1.88.
Anderegg CR, Martin SJ, Gray JL, et al. Clinical evaluation of the use of decalcified freeze-dried bone allograft with guided tissue regeneration in the treatment of molar furcation invasions. J Periodontol 1991;62:264-8.
Luepke PG, Mellonig JT, Brunsvold MA. A clinical evaluation of a bioresorbable barrier with and without decalcified freeze-dried bone allograft in the treatment of molar furcations. J Clin Periodontol 1997;24(6):440–446. DOI: 10.1111/j.1600-051x.1997.tb00209.x.
Bowers GM, Granet M, Stevens M, et al. Histologic evaluation of new attachment in humans. A preliminary report. J Periodontol 1985;56(7):381–396. DOI: 10.1902/jop.1985.56.7.381.
Becker W, Becker BE, Caffesse R. A comparison of demineralized freeze-dried bone and autologous bone to induce bone formation in human extraction sockets. J Periodontol 1994;65(12):1128–1133. DOI: 10.1902/jop.1994.65.12.1128.
Reynolds MA, Bowers GM. Fate of demineralized freeze-dried bone allografts in human intrabony defects. J Periodontol 1996;67(2):150–157. DOI: 10.1902/jop.1996.67.2.150.
Shigeyama Y, D'Errico JA, Stone R, et al. Commercially-prepared allograft material has biological activity in vitro. J Periodontol 1995;66(6):478–487. DOI: 10.1902/jop.1995.66.6.478.
Becker W, Urist MR, Tucker LM, et al. Human demineralized freeze-dried bone: Inadequate induced bone formation in athymic mice. J Periodontol 1995;66(9):822–828. DOI: 10.1902/jop.1995.66.9.822.
Yukna RA, Evans GH, Aichelmann-Reidy MB, et al. Clinical comparison of bioactive glass bone replacement graft material and expanded polytetrafluoroethylene barrier membrane in treating human mandibular molar class II furcations. J Periodontol 2001;72(2):125–133. DOI: 10.1902/jop.2001.72.2.125.
Becker W, Becker BE, Berg L, et al. New attachment after treatment with root isolation procedures: Report for treated Class II and Class II furcation and vertical osseous defects. Int J Periodontics Restorative Dent 1988;8(3):8–23. PMID: 3251875.
Evans GH, Yukna RA, Gardiner DL, et al. Frequency of furcation closure with regenerative periodontal therapy. J West Soc Periodontol Periodontal Abstr 1996;44(4):101–109. PMID: 9477865.